ArticleThe journal of pathology. Clinical research2025

Inter-rater agreement of HER2-low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797).

Suzanne Parry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.